Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


11 Items
Title  Creator  Group name  Publishing year 
PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells Aptecar et al. EquipeMY 2023-10-21
Protein Phosphorylation in Cancer: Unraveling the Signaling Pathways Coopman EquipePC 2022-07-27
The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest Pichard et al. EquipeNB May 2020
Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer Mcheik et al. EquipePC 2020-12-11
The Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin Complex Kassouf et al. EquipePC Dec 07, 2019
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro Tümmler et al. EquipePC Feb 10, 2019
FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer Mangé et al. PlateformePP2I 2019
High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcome D'Hondt et al. EquipePC Nov 10, 2017
Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches Vendrell et al. EquipePC 10 02, 2017
Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management Vendrell et al. EquipePC Jan 29, 2017
An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma Mangé et al. PlateformePP2I 06 16, 2016
11 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés